Baroque Pharmaceuticals Pvt.Ltd. India Revenue and Competitors

Khambhat (Cambay)-Dist Anand, IND

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Baroque Pharmaceuticals Pvt.Ltd. India's estimated annual revenue is currently $9.9M per year.(i)
  • Baroque Pharmaceuticals Pvt.Ltd. India's estimated revenue per employee is $100,500

Employee Data

  • Baroque Pharmaceuticals Pvt.Ltd. India has 99 Employees.(i)
  • Baroque Pharmaceuticals Pvt.Ltd. India grew their employee count by 15% last year.

Baroque Pharmaceuticals Pvt.Ltd. India's People

NameTitleEmail/Phone
1
Senior Executive Human ResourcesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$56.6M56321%N/AN/A
#2
$15.6M15528%N/AN/A
#3
$17M169-11%N/AN/A
#4
$13.2M1318%N/AN/A
#5
$19.6M19510%N/AN/A
#6
$23.5M2347%N/AN/A
#7
$5.3M530%N/AN/A
#8
$13M129-25%N/AN/A
#9
$20.5M20411%N/AN/A
#10
$11.7M1166%N/AN/A
Add Company

What Is Baroque Pharmaceuticals Pvt.Ltd. India?

We are a Company based at Cambay, Gujarat State, in India involved in the manufacturing & marketing of pharmaceutical formulations established in the year 1994. The board of the company comprise of technocrats who have the basic technical education in the fields of pharmacy & medicine which is amplified by a vast experience in pharmaceutical manufacturing & managing a pharmaceutical industry. Our core activities are : - 1) Manufacturing of formulations 2) Marketing of formulations across the Country. 3) Export of Formulations 4) Contract Manufacturing (On Loan License and P to P basis ) We are a ISO 9001:2008 certified company. Our manufacturing site is Revised Schedule M compliant and has a WHO GMP approval. The site has facilities to manufacture General tablets, capsules, dry powders & liquids and Betalactum tablets, capsules, dry syrup & ready mix. Our products are being marketed in India as well as exported to over 14 countries world wide.

keywords:N/A

N/A

Total Funding

99

Number of Employees

$9.9M

Revenue (est)

15%

Employee Growth %

N/A

Valuation

N/A

Accelerator